Form D · Biotechnology
Immunaeon Inc.
Buffalo, NY · CIK 0001971360
Offering snapshot reported Apr 4, 2023 · SEC filing
- Reported sold
- $250K Indefinite offering
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $5K Reported outside-investor minimum
- First sale
- Feb 23, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 4, 2023 | Initial | $250,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Option to acquire, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-477830
Simple Agreement for Future Equity
Source: Form D, filed Apr 4, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Joseph Dinardo | Executive |
| Daniel Rera | Executive |
| Adam Utley | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
701 Ellicott Street
Buffalo, NY, 14203
Buffalo, NY, 14203